These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 21811192
1. Escitalopram versus placebo in the treatment of dysthymic disorder. Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D. Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192 [Abstract] [Full Text] [Related]
2. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y. J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV. Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [Abstract] [Full Text] [Related]
4. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Bose A, Korotzer A, Gommoll C, Li D. Depress Anxiety; 2008 Nov; 25(10):854-61. PubMed ID: 18050245 [Abstract] [Full Text] [Related]
5. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice. Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB. Psychopharmacol Bull; 2007 Nov; 40(1):63-73. PubMed ID: 17285097 [Abstract] [Full Text] [Related]
6. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T. J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597 [Abstract] [Full Text] [Related]
7. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Colonna L, Andersen HF, Reines EH. Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906 [Abstract] [Full Text] [Related]
8. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M. Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832 [Abstract] [Full Text] [Related]
13. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. Khin NA, Chen YF, Yang Y, Yang P, Laughren TP. J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123 [Abstract] [Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A. J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]